References

1. Ximino Capsules. Prescribing Information. Jacksonville, FL: Ranbaxy Laboratories Inc; September 2015.

2. Del Rosso JQ. Weight-based dosing and extended-release formulation of minocycline tablets: Is there clinical significance? J Clin Aesthet Dermatol. 2009;2(1):44-47.

3. Stewart DM, Torok HM, Weiss JS, Plott RT; Solodyn Phase 2 Study Group. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris. Cutis. 2006;78(4 Suppl):11-20.

4. Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician. 2000;62(8):1823-1830.

5. Overgaard AB, Højsted J, Hansen R, Møller-Sonnergaard, Christrup LL. Patients' evaluation of shape, size and colour of solid dosage forms. Pharm World Sci. 2001;23(5):185-188.

6. American Academy of Dermatology. Acne: who gets and causes. https://www.aad.org/public/diseases/acne-and-rosacea/acne. Accessed March 15, 2016.

7. US Dept of Health and Human Services. What is acne? http://www.niams.nih.gov/Health_Info/Acne/acne_ff.pdf. Updated November 2014. Accessed March 21, 2016.

8. American Academy of Dermatology. Acne tips for managing. https://www.aad.org/public/diseases/acne-and-rosacea/acne. Accessed December 7, 2016.

9. American Academy of Dermatology. Two myths and a truth. https://www.aad.org/public/kids/good-skin-knowledge-lesson-plans-and-activities/acne/acne-myths-and-truths-ages-11-13. Accessed December 7, 2016.